Prot #M14-011: A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant C

Project: Research project

Project Details

Effective start/end date4/23/154/23/23


  • Alliance Foundation Trials, LLC (Prot #M14-011 // Prot #M14-011)
  • AbbVie Inc. (Prot #M14-011 // Prot #M14-011)